Case Report
Hyperechogenicity of the Substantia Nigra in Parkinson’s Disease: Insights from Two Brothers with Markedly Different Disease Durations
Table 1
Demographical and clinical characteristics.
| |||||||||||||||||||||||||||||||||||||||||||||
H&Y: Hoehn and Yahr Clinical staging; MDS-UPDRS: Movement Disorder Society-Unified Parkinson’s Disease Rating Scale; LED: Levodopa equivalent dose; MMSE: Mini Mental State Examination; BDI-II: Beck Depression Inventory-II; RBDQ: REM Sleep Behaviour Disorder Questionnaire. |